Nova Eye Medical Limited

A$0.14As of Sun 8 Nov 2026, 12:00 UTC
ASX:EYEHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (12.76%)
Div yield —
ROE (26.07%)
Medical Devices
Beta (5Y) 0.83
PE TTM —
TSR TTM 3.70%
Mkt cap A$39.89M
ROIC (27.86%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.142
1.75%
(85.95%)
Hold 8|7|10|5|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
28.08%
24.11%
11.39%
(0.62%)
Revenue$M
4.468
4.627
4.555
4.489
13.42%
14.26%
7.74%
1.83%
Peers (US$27.40M)
Cap (US$)
PE
29.44M
—
Capital
TTM
5Y
10Y
Leveragex
0.598
2.310
2.257
EBIT/Intx
1.211
0.077
0.079
Own earn%
(22.87)
(5.82)
(8.94)
Sh yield%
24.28
16.18
22.37
Owners
Insiders/Inst%
12.35
66.47
Short interest%
3.46
SBC / revenue%
4.76
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
16–25
$1 testx
—
Incr. ROIC%
1